M D Minden
Impact in
- Hematology top 5%
- Acute Myeloid Leukemia Research
- Hematopoietic Stem Cell Transplantation
- Chronic Myeloid Leukemia Treatments
-
- Mast cells and histamine
- Immune Cell Function and Interaction
Papers in
-
- Acute Myeloid Leukemia Research 7
- Chronic Myeloid Leukemia Treatments 3
- Hematopoietic Stem Cell Transplantation 3
-
- Cancer therapeutics and mechanisms 3
- Retinoids in leukemia and cellular processes 2
- Ubiquitin and proteasome pathways 2
- Co-authors
- McCulloch Ea (9 shared papers)Curtis Je (5 shared papers)C Wang (2 shared papers)Henry H. Heng (2 shared papers)David P. Siderovski (2 shared papers)Stephen Clark (1 shared paper)C. A. Kelleher (1 shared paper)GG Wong (1 shared paper)
- Journals
- Leukemia (1 paper)IEEE Transactions on Computers (1 paper)arXiv (Cornell University) (1 paper)Munich Personal RePEc Archive (Ludwig Maximilian University of Munich) (1 paper)PubMed (15 papers)
- Partner nations
- CanadaItalyUnited States
In The Last Decade
M D Minden
19 papers receiving 498 citations
Peers
Comparison fields: 5 of 77
- Hematology 260
- Immunology 131
- Genetics 59
- Immunology and Allergy 23
- Molecular Biology 256
Countries citing papers authored by M D Minden
This map shows the geographic impact of M D Minden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M D Minden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M D Minden more than expected).
Fields of papers citing papers by M D Minden
This network shows the impact of papers produced by M D Minden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M D Minden. The network helps show where M D Minden may publish in the future.
Co-authors
The 25 scholars most cited alongside M D Minden, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | The expression of the proto-oncogene C-kit in the blast cells of acute myeloblastic leukemia. | 1989 | 137 |
| 2 | Expression of a retinoic acid receptor gene in myeloid leukemia cells. | 1989 | 89 |
| 3 | Binding of iodinated recombinant human GM-CSF to the blast cells of acute myeloblastic leukemia. | 1988 | 47 |
| 4 | Differential expression of a basic helix-loop-helix phosphoprotein gene, G0S8, in acute leukemia and localization to human chromosome 1q31. | 1995 | 36 |
| 5 | Long-term results of bone marrow transplantation for patients with AML, ALL and CML prepared with single dose total body irradiation of 500 cGy delivered with a high dose rate. | 1991 | 34 |
| 6 | Acute myeloblastic leukemia considered as a clonal hemopathy. | 1979 | 33 |
| 7 | Identification of a human LIM-Hox gene, hLH-2, aberrantly expressed in chronic myelogenous leukaemia and located on 9q33-34.1. | 1996 | 33 |
| 8 | Post-transcriptional regulation of bcl-2 in acute myeloblastic leukemia: significance for response to chemotherapy. | 1996 | 32 |
| 9 | Heterogeneity in acute myeloblastic leukemia. | 1988 | 19 |
| 10 | Interactions between retinoic acid and colony-stimulating factors affecting the blast cells of acute myeloblastic leukemia. | 1991 | 16 |
| 11 | Minimal residual disease in bone marrow transplant recipients with chronic myeloid leukemia. | 1994 | 9 |
| 12 | The isolation of the human delta chain gene and its expression in normal T cells and T cell leukemias. | 1988 | 8 |
| 13 | 1982 | 7 | |
| 14 | Restriction fragment length polymorphism analysis of hematopoietic cells following successful treatment of relapsed acute lymphoblastic leukemia following bone marrow transplantation. | 1989 | 5 |
| 15 | Response of the blast stem cells of acute myeloblastic leukemia to G-CSF, GM-CSF, or the ligand for C-KIT, alone or in combination. | 1996 | 4 |
| 16 | Fluorescence-labeling of nicks in DNA from leukemic blast cells as a measure of damage following cytosine arabinoside. Application to the study of regulated drug sensitivity. | 1994 | 3 |
| 17 | On Subcomplete Forcing | 2017 | 2 |
| 18 | Three decades of allogeneic bone marrow transplants at the Princess Margaret Hospital. | 1999 | 2 |
| 19 | Clonal expansion and progression in acute myeloblastic leukemia. | 1978 | 1 |
About M D Minden
M D Minden is a scholar working on Hematology, Molecular Biology, Genetics, Oncology and Public Health, Environmental and Occupational Health, having authored 19 papers that have together received 517 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (7 papers), Chronic Myeloid Leukemia Treatments (3 papers), Cancer therapeutics and mechanisms (3 papers), Hematopoietic Stem Cell Transplantation (3 papers), Acute Lymphoblastic Leukemia research (2 papers), Retinoids in leukemia and cellular processes (2 papers), Ubiquitin and proteasome pathways (2 papers) and Metal Forming Simulation Techniques (1 paper). The work is most often cited by research in Hematology (260 citations), Immunology (131 citations), Genetics (59 citations), Immunology and Allergy (23 citations) and Molecular Biology (256 citations). M D Minden has collaborated with scholars based in Canada, Italy and United States. Frequent co-authors include McCulloch Ea, Curtis Je, C Wang, Henry H. Heng, David P. Siderovski, Stephen Clark, C. A. Kelleher, GG Wong, Paul F. Schendel and E. A. McCulloch. Their work appears in journals such as Leukemia, IEEE Transactions on Computers, arXiv (Cornell University), Munich Personal RePEc Archive (Ludwig Maximilian University of Munich) and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.